NASDAQ:HRMY

Harmony Biosciences Holdings Stock News

etoro logo Buy HRMY
*Your capital is at risk
$35.24
-0.620 (-1.73%)
At Close: Jul 31, 2026
Inherently, investors gravitate toward strong buy value stocks, in much the same way that audience members of a horror film might grip their armrests. As humans, we're basically hardwired – especial
Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.56 per share, missing the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.57 per share a y
Harmony Biosciences is a high-margin, high-growth pharmaceutical business, attracting the attention of short sellers. The company's short position is significant. 38% of float has been borrowed then p
PLYMOUTH MEETING, Pa. , July 18, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializ
Generally speaking, financial advisors will often direct you to reliable enterprises though, for certain folks, high-growth stocks may make more sense. That's particularly true if you're part of the y
The biotech sector will always house stocks with explosive upside potential. The very nature of the sector ensures that will continue to be the case.
PLYMOUTH MEETING, Pa. , May 30, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializin
Late-breaking Phase 2 proof-of-concept study in Prader-Willi syndrome accepted for poster presentation PLYMOUTH MEETING, Pa. , May 10, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY ) Q1 2023 Earnings Conference Call May 2, 2023 8:30 AM ET Company Participants Luis Sanay - Head, IR Jeffrey Dayno - President and CEO Jeffrey Dierks -
Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.51 per share a y
PLYMOUTH MEETING, Pa. , April 20, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercial

7 Stocks to Buy to Bag Big-Time Returns in Q2

02:01pm, Sunday, 16'th Apr 2023
If you're the type that runs toward danger, these stocks to buy may be right for you. To facilitate mobility, the enterprises on this list feature a market capitalization between $500 million to $2 bi

7 Biotech Stocks to Buy for 100% Returns

01:19pm, Sunday, 09'th Apr 2023
Generally speaking, biotech stocks to buy offer investors an excellent opportunity for significant upside success. According to Grand View Research, the global market size for the industry reached $1.
Harmony Biosciences Holdings, Inc. (HRMY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into
Harmony has only one approved therapy, Wakix, to treat excessive daytime sleepiness. The drug was responsible for all of the company's revenue in 2022.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE